176 related articles for article (PubMed ID: 25874882)
1. iTRAQ-based quantitative proteomic analysis on S100 calcium binding protein A2 in metastasis of laryngeal cancer.
Zha C; Jiang XH; Peng SF
PLoS One; 2015; 10(4):e0122322. PubMed ID: 25874882
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.
Lauriola L; Michetti F; Maggiano N; Galli J; Cadoni G; Schäfer BW; Heizmann CW; Ranelletti FO
Int J Cancer; 2000 Jul; 89(4):345-9. PubMed ID: 10956408
[TBL] [Abstract][Full Text] [Related]
3. The Ca2+-binding S100A2 protein is differentially expressed in epithelial tissue of glandular or squamous origin.
Nagy N; Hoyaux D; Gielen I; Schäfer BW; Pochet R; Heizmann CW; Kiss R; Salmon I; Decaestecker C
Histol Histopathol; 2002 Jan; 17(1):123-30. PubMed ID: 11813862
[TBL] [Abstract][Full Text] [Related]
4. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis.
Feng G; Xu X; Youssef EM; Lotan R
Cancer Res; 2001 Nov; 61(21):7999-8004. PubMed ID: 11691825
[TBL] [Abstract][Full Text] [Related]
5. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
6. Diminished expression of S100A2, a putative tumour suppressor, is an independent predictive factor of neck node relapse in laryngeal squamous cell carcinoma.
Almadori G; Bussu F; Galli J; Rigante M; Lauriola L; Michetti F; Maggiano N; Schafer BW; Heizmann CW; Ranelletti FO; Paludetti G
J Otolaryngol Head Neck Surg; 2009 Feb; 38(1):16-22. PubMed ID: 19344608
[TBL] [Abstract][Full Text] [Related]
7. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
[TBL] [Abstract][Full Text] [Related]
9. iTRAQ-based quantitative proteomic analysis of cervical cancer.
Ding Y; Yang M; She S; Min H; Xv X; Ran X; Wu Y; Wang W; Wang L; Yi L; Yang Y; Gao Q
Int J Oncol; 2015 Apr; 46(4):1748-58. PubMed ID: 25633909
[TBL] [Abstract][Full Text] [Related]
10. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
11. [Expression of S100A2 in secondarily radioresistant pancreatic cancer cells and significance thereof].
Wen Q; Zhao YP; Chen G; Zhang FQ; Zhang TP
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2817-20. PubMed ID: 17200013
[TBL] [Abstract][Full Text] [Related]
12. Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer.
Strazisar M; Rott T; Glavac D
Lung Cancer; 2009 Mar; 63(3):354-9. PubMed ID: 18656279
[TBL] [Abstract][Full Text] [Related]
13. S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity.
Suzuki F; Oridate N; Homma A; Nakamaru Y; Nagahashi T; Yagi K; Yamaguchi S; Furuta Y; Fukuda S
Oncol Rep; 2005 Dec; 14(6):1493-8. PubMed ID: 16273244
[TBL] [Abstract][Full Text] [Related]
14. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
15. The expression and function of epithelial membrane protein 1 in laryngeal carcinoma.
Li H; Zhang X; Jiang X; Ji X
Int J Oncol; 2017 Jan; 50(1):141-148. PubMed ID: 27909719
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of altered S100A2 expression in gastric cancer.
Zhao Y; Zhang TB; Wang Q
Oncol Rep; 2013 Apr; 29(4):1556-62. PubMed ID: 23337980
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer.
Wang H; Zhang Z; Li R; Ang KK; Zhang H; Caraway NP; Katz RL; Jiang F
Int J Cancer; 2005 Aug; 116(2):285-90. PubMed ID: 15800916
[TBL] [Abstract][Full Text] [Related]
18. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.
Tyszkiewicz T; Jarzab M; Szymczyk C; Kowal M; Krajewska J; Jaworska M; Fraczek M; Krajewska A; Hadas E; Swierniak M; Markowski J; Lange D; Poltorak S; Wiench M; Krecicki T; Jarzab J; Maciejewski A
Folia Histochem Cytobiol; 2014; 52(2):79-89. PubMed ID: 25007175
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.
Kyriazanos ID; Tachibana M; Dhar DK; Shibakita M; Ono T; Kohno H; Nagasue N
Oncol Rep; 2002; 9(3):503-10. PubMed ID: 11956617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
